Research Methodology – Gastrointestinal Drugs Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Gastrointestinal Drugs Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Gastrointestinal Drugs Market is developed by integrating key market indicators and macroeconomic variables. These include:
1 Factors considered while calculating market size and share
- Number of patients suffering from gastrointestinal diseases
- The price of each drug in the market
- Prescription pattern and frequency of drug usage
- Approval of new gastrointestinal drugs
- Healthcare expenditure capacity of the population
- Market penetration of different gastrointestinal drugs
- Drug patent status and its effect on sales
- Insurance coverage and government policies impacting drug pricing
2 Key Market Indicators
- The prevalence and incidence rates of gastrointestinal diseases
- Research and development activities in gastrointestinal drugs
- Revenue generated by major players in the market
- Approval and launch of new drugs
- Healthcare expenditure as a percentage of GDP
- The import and export trends of gastrointestinal drugs
- Market share of generic drugs versus patented drugs
- Consumer preference towards natural and organic medicines
3 Growth Trends
- Increasing demand for over-the-counter gastrointestinal drugs
- Growth in the geriatric population more prone to gastrointestinal disorders
- Increasing research activities for drug development in the gastrointestinal sector
- Emergence of personalised medicine and genetic testing in treatment of gastrointestinal diseases
- Shift towards natural and herbal medicines for the treatment of gastrointestinal disorders
- Increasing healthcare expenditure and growing accessibility to advanced healthcare facilities
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Gastrointestinal Drugs Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Gastrointestinal Drugs Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
